$ATRX Adhera Therapeutics is a clinical stage biopharmaceutical company focused on identifying advanced drug candidates that may qualify for accelerated developmental pathways. $PDSB PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101.